Loading clinical trials...
Loading clinical trials...
A Prospective Clinical Study Evaluating the Effects of a Skin Boosting Injectable on the Aesthetic Improvement of Facial Rhytids
Conditions
Interventions
Revanesse® Renew™+
Locations
1
Canada
Erevna Innovations Inc.
Montreal, Quebec, Canada
Start Date
February 25, 2026
Primary Completion Date
February 25, 2027
Completion Date
March 25, 2027
Last Updated
February 5, 2026
NCT07151859
NCT07079397
NCT07202117
NCT07261748
NCT07188818
NCT07370545
Lead Sponsor
Erevna Innovations Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions